Neimeth Explains Agenda For N5b Fresh Capital
Shareholders of Neimeth International Pharmaceuticals PLC have approved the plan of the Board to raise the sum of N5 billion through a hybrid offering of Rights to existing shareholders and private placement. The money will be used to finance major...